UK-US Trade Deals: Medicines Pact & Tech Sovereignty Row
New UK-US medicines agreement aims to boost NHS access to innovative drugs, but critics warn of eroded sovereignty in wider trade pacts with Trump. Explore the debate.
New UK-US medicines agreement aims to boost NHS access to innovative drugs, but critics warn of eroded sovereignty in wider trade pacts with Trump. Explore the debate.
UK ministers propose 25% increase in NHS drug cost-effectiveness thresholds to resolve investment row with pharmaceutical giants and boost life sciences sector.